跳至主要内容
临床试验/DRKS00012661
DRKS00012661已完成2 期

Safety and efficacy of the treatment with the beecura beehive air therapy system BCS-IH16 - swarm study

APIPRO Natura0 个研究点目标入组 30 人开始时间: 2018年4月30日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • patients must be capable to fill out an questionnaire on their quality of life
  • - patients with a COPD or Asthma bronchiale and FEV1 between 50 % and 80 %
  • - stable pulmonary medication without any changes in the last seven days
  • - written informed consent

排除标准

  • - acute exacerbation of the pulmonary disease
  • - allergy against bee or wasp stings
  • - restrictive lung disorders
  • - malignant disease which is not yet cured
  • - diseases with a life expectancy less than 6 months
  • - heart insufficiency with an ejection fraction of less than 40 %
  • - imprisoned individuals or mental immature adults
  • - pregnant or breastfeeding patients
  • - women of child bearing potential not using contraception
  • - drug and alcohol abuse
  • - patients not capable of giving consent
  • - severe cognitive deficits or dementia
  • - participation in other clinical studies
  • - persons who may be dependet on the sponsor or investigator

研究者

发起方
APIPRO Natura

相似试验